Your trusted CRO partner for preclinical studies of kidney disease
Our mission is to accelerate the development of novel therapies to treat kidney disease by combining scientific excellence with robust and reproducible preclinical models.
Our services
We provide high-quality, cost-effective in vivo and ex vivo models to study acute and chronic kidney disease and diabetic nephropathy. We are located at Karolinska Institutet 's campus in Stockholm with access to state-of-the-art technologies, including in vivo imaging, single-cell and bulk RNA sequencing, spatial transcriptomics, proteomics, super-resolution microscopy and AI-assisted histology analysis.
About us
Alvolab (from the Portuguese word 'Alvo', meaning 'Target') is a contract research organization specialized in preclinical studies of kidney disease. Founded in 2023 as a spin-off from Karolinska Institutet, our team brings over 30 years of experience in translational kidney research from leading academic institutions including Harvard Medical School, Karolinska Institutet, and Uppsala University, as well as from the pharmaceutical industry.
Our mission is to accelerate the development of novel therapies to treat kidney disease by combining scientific excellence with robust and reproducible preclinical models. To that end, we provide high-quality, cost-effective in vivo and ex vivo models to study acute and chronic kidney disease and diabetic nephropathy.
Contact us to learn more about our services and what we can do for your organization or company.
Jenny van Asbeck-van der Wijst, PhD MBA, CEO Mercurna
We are pleased to collaborate with Alvolab, whose broad range of kidney disease models and deep expertise in relevant assays and readouts have been invaluable to our preclinical studies. We also greatly appreciate their clear communication and collaborative approach. We highly recommend Alvolab for their reliable, high-quality preclinical CRO services
Tobias Larsson Agervald, MD PhD, CEO Guard Therapeutics
We've partnered with Alvolab on several preclinical kidney disease programs and have been consistently impressed by the scientific quality and reliability of their work. Their broad expertise and cost-effective services make them a trusted partner. I highly recommend them to any company working in nephrology.